Total Payments
$43,611
2024 Payments
$9,600
Companies
4
Transactions
17
Medicare Patients
2,929
Medicare Billing
$1.2M
Payment Breakdown by Category
Other$30,900 (70.9%)
Education$12,613 (28.9%)
Food & Beverage$97.41 (0.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Long term medical supply or device loan | $28,800 | 6 | 66.0% |
| Education | $12,613 | 4 | 28.9% |
| Debt forgiveness | $2,100 | 1 | 4.8% |
| Food and Beverage | $97.41 | 6 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AngioDynamics, Inc. | $43,532 | 12 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $30.96 | 2 | $0 (2018) |
| Medtronic Vascular, Inc. | $30.94 | 2 | $0 (2019) |
| AstraZeneca Pharmaceuticals LP | $16.48 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $9,600 | 2 | AngioDynamics, Inc. ($9,600) |
| 2023 | $11,700 | 3 | AngioDynamics, Inc. ($11,700) |
| 2022 | $9,600 | 2 | AngioDynamics, Inc. ($9,600) |
| 2021 | $9,600 | 2 | AngioDynamics, Inc. ($9,600) |
| 2020 | $2,400 | 1 | AngioDynamics, Inc. ($2,400) |
| 2019 | $644.27 | 3 | AngioDynamics, Inc. ($613.33) |
| 2018 | $54.97 | 3 | Janssen Pharmaceuticals, Inc ($19.46) |
| 2017 | $11.50 | 1 | Janssen Pharmaceuticals, Inc ($11.50) |
All Payment Transactions
17 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/31/2024 | AngioDynamics, Inc. | VenaCure 1470 Pro (Device) | Long term medical supply or device loan | In-kind items and services | $4,800.00 | General |
| Category: ET | ||||||
| 12/31/2024 | AngioDynamics, Inc. | VenaCure 1470 Pro (Device) | Long term medical supply or device loan | In-kind items and services | $4,800.00 | General |
| Category: ET | ||||||
| 12/31/2023 | AngioDynamics, Inc. | VenaCure 1470 Pro (Device) | Long term medical supply or device loan | In-kind items and services | $4,800.00 | General |
| Category: ET | ||||||
| 12/31/2023 | AngioDynamics, Inc. | VenaCure 1470 Pro (Device) | Long term medical supply or device loan | In-kind items and services | $4,800.00 | General |
| Category: ET | ||||||
| 10/26/2023 | AngioDynamics, Inc. | VenaCure EVLT (Device) | Debt forgiveness | In-kind items and services | $2,100.00 | General |
| Category: VIT | ||||||
| 12/31/2022 | AngioDynamics, Inc. | VenaCure 1470 Pro (Device) | Long term medical supply or device loan | In-kind items and services | $4,800.00 | General |
| Category: ET | ||||||
| 12/31/2022 | AngioDynamics, Inc. | VenaCure 1470 Pro (Device) | Long term medical supply or device loan | In-kind items and services | $4,800.00 | General |
| Category: ET | ||||||
| 12/31/2021 | AngioDynamics, Inc. | VenaCure 1470 Pro (Device) | Education | In-kind items and services | $4,800.00 | General |
| Category: ET | ||||||
| 12/31/2021 | AngioDynamics, Inc. | VenaCure 1470 Pro (Device) | Education | In-kind items and services | $4,800.00 | General |
| Category: ET | ||||||
| 12/31/2020 | AngioDynamics, Inc. | EVLT (Device) | Education | In-kind items and services | $2,400.00 | General |
| Category: Peripheral Vascular | ||||||
| 12/31/2019 | AngioDynamics, Inc. | EVLT (Device) | Education | In-kind items and services | $613.33 | General |
| Category: Peripheral Vascular | ||||||
| 12/04/2019 | Medtronic Vascular, Inc. | ClosureRFG (Device) | Food and Beverage | In-kind items and services | $17.07 | General |
| Category: EndoVenous Therapies | ||||||
| 08/23/2019 | Medtronic Vascular, Inc. | ClosureFast (Device) | Food and Beverage | In-kind items and services | $13.87 | General |
| Category: EndoVenous Therapies | ||||||
| 10/22/2018 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $16.48 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 04/18/2018 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $19.46 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 01/05/2018 | AngioDynamics, Inc. | — | Food and Beverage | In-kind items and services | $19.03 | General |
| Category: VIT | ||||||
| 01/26/2017 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $11.50 | General |
| Category: Cardiovascular & Metabolism | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2022 | 9 | 669 | 1,027 | $1.3M | $219,882 |
| 2021 | 8 | 1,271 | 2,350 | $2.9M | $555,572 |
| 2020 | 10 | 989 | 1,660 | $2.0M | $393,596 |
Total Patients
2,929
Total Services
5,037
Medicare Billing
$1.2M
Procedure Codes
27
All Medicare Procedures & Services
27 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 36475 | Destruction of first incompetent vein of arm or leg using radiofrequency and imaging guidance | Office | 2022 | 62 | 159 | $858,600 | $134,145 | 15.6% |
| 93970 | Ultrasound study of arm or leg veins with compression and maneuvers | Office | 2022 | 184 | 214 | $160,500 | $28,327 | 17.6% |
| 93971 | Ultrasound study of one arm or leg veins with compression and maneuvers | Office | 2022 | 100 | 248 | $124,000 | $21,688 | 17.5% |
| 36471 | Injection of chemical agent into multiple incompetent veins of leg | Office | 2022 | 73 | 139 | $83,400 | $20,232 | 24.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 101 | 112 | $16,150 | $6,880 | 42.6% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 90 | 90 | $13,100 | $5,772 | 44.1% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 37 | 42 | $3,150 | $1,759 | 55.8% |
| 36470 | Injection of chemical agent into single incompetent vein | Office | 2022 | 11 | 12 | $4,200 | $884.79 | 21.1% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2022 | 11 | 11 | $550.00 | $194.72 | 35.4% |
| 36475 | Destruction of insufficient vein of arm or leg, accessed through the skin | Office | 2021 | 115 | 315 | $1.7M | $304,470 | 17.9% |
| 36471 | Injection of chemical agent into multiple incompetent veins of one leg | Office | 2021 | 196 | 507 | $300,950 | $74,214 | 24.7% |
| 93970 | Ultrasound scan of veins of both arms or legs including assessment of compression and functional maneuvers | Office | 2021 | 296 | 430 | $322,500 | $57,519 | 17.8% |
| 93971 | Ultrasound scan of veins of one arm or leg or limited including assessment of compression and functional maneuvers | Office | 2021 | 180 | 503 | $251,500 | $45,973 | 18.3% |
| 36478 | Laser destruction of incompetent vein of arm or leg using imaging guidance, accessed through the skin | Office | 2021 | 38 | 47 | $253,800 | $38,817 | 15.3% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 267 | 369 | $53,100 | $23,333 | 43.9% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 152 | 152 | $15,200 | $10,791 | 71.0% |
| 99211 | Established patient outpatient visit, minimal presenting problem | Office | 2021 | 27 | 27 | $1,350 | $454.97 | 33.7% |
| 36475 | Destruction of insufficient vein of arm or leg, accessed through the skin | Office | 2020 | 93 | 195 | $1.1M | $203,416 | 19.3% |
| 36471 | Injection of chemical agent into multiple incompetent veins of one leg | Office | 2020 | 148 | 340 | $196,200 | $50,865 | 25.9% |
| 36478 | Laser destruction of incompetent vein of arm or leg using imaging guidance, accessed through the skin | Office | 2020 | 37 | 57 | $307,800 | $43,750 | 14.2% |
| 93971 | Ultrasound scan of veins of one arm or leg or limited including assessment of compression and functional maneuvers | Office | 2020 | 160 | 418 | $208,300 | $38,223 | 18.3% |
| 93970 | Ultrasound scan of veins of both arms or legs including assessment of compression and functional maneuvers | Office | 2020 | 214 | 236 | $176,700 | $33,039 | 18.7% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 196 | 241 | $24,100 | $13,801 | 57.3% |
| 99203 | New patient office or other outpatient visit, typically 30 minutes | Office | 2020 | 88 | 88 | $8,800 | $6,534 | 74.2% |
| 76942 | Ultrasonic guidance imaging supervision and interpretation for insertion of needle | Office | 2020 | 31 | 60 | $39,800 | $2,456 | 6.2% |
About Dr. Steven Folstad, M.D
Dr. Steven Folstad, M.D is a Phlebology healthcare provider based in Mooresville, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/19/2006. The National Provider Identifier (NPI) number assigned to this provider is 1558314575.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Steven Folstad, M.D has received a total of $43,611 in payments from pharmaceutical and medical device companies, with $9,600 received in 2024. These payments were reported across 17 transactions from 4 companies. The most common payment nature is "Long term medical supply or device loan" ($28,800).
As a Medicare-enrolled provider, Folstad has provided services to 2,929 Medicare beneficiaries, totaling 5,037 services with total Medicare billing of $1.2M. Data is available for 3 years (2020–2022), covering 27 distinct procedure/service records.
Ad
Practice Information
- Specialty Phlebology
- Other Specialties Emergency Medicine
- Location Mooresville, NC
- Active Since 05/19/2006
- Last Updated 01/02/2024
- Taxonomy Code 202K00000X
- Entity Type Individual
- NPI Number 1558314575
Products in Payments
- VenaCure 1470 Pro (Device) $38,400
- EVLT (Device) $3,013
- VenaCure EVLT (Device) $2,100
- XARELTO (Drug) $30.96
- ClosureRFG (Device) $17.07
- LOKELMA (Drug) $16.48
- ClosureFast (Device) $13.87
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.